UCLH launches walking aid 'return and reuse' scheme
11 August 2022
Publish date: 01 December 2020
The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.
The legal case was brought against the Tavistock and Portman NHS Trust which leads the national Gender Identity and Development Service (GIDS). The puberty blocking drugs provided by the service are prescribed and administered by endocrinologists at UCLH and Leeds Teaching Hospitals NHS Trust.
Our statement in response to the ruling is as follows:
A UCLH spokesperson said: “We are disappointed with the court’s decision. The Tavistock and Portman NHS Foundation Trust is seeking permission to appeal this judgement and we support this. Our priority is our patients and we will be working closely with the Tavistock to support those affected by the court’s ruling.”
Further information is available on the GIDS website: www.gids.nhs.uk
If you are a patient or parent concerned about the ruling please call 07812 512 126. This number is for patients and their families only.
Journalists should email email@example.com. This email address is for members of the media only.
21 July 2022